Back to results
WithdrawnPhase 2

T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer

NCT04351230

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Yuma Regional Medical Center

Yuma, Arizona, United States

+5 additional locations

View on ClinicalTrials.gov
T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer — TrialFind